George Sellers
Stock Analyst at Stephens & Co.
(1.34)
# 3,418
Out of 4,876 analysts
43
Total ratings
27.27%
Success rate
-6.66%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $40.84 | +66.50% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $119.58 | +142.52% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $41.66 | +39.22% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $130.06 | +36.86% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $10.75 | +123.26% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $32.26 | +123.19% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $2.18 | +129.36% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $5.59 | +347.23% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $16.81 | +239.08% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $101.06 | -29.74% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $40.84
Upside: +66.50%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $119.58
Upside: +142.52%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $41.66
Upside: +39.22%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $130.06
Upside: +36.86%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $10.75
Upside: +123.26%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $32.26
Upside: +123.19%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $2.18
Upside: +129.36%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $5.59
Upside: +347.23%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $16.81
Upside: +239.08%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $101.06
Upside: -29.74%